PRICES include / exclude VAT
>BSI Standards >11 HEALTH CARE TECHNOLOGY>11.080 Sterilization and disinfection>11.080.20 Disinfectants and antiseptics>BS EN 16615:2026 Chemical disinfectants and antiseptics. Quantitative test method for the evaluation of bactericidal and yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity on non-porous surfaces with mechanical action employing wipes or mops in the medical area (4- field test). Test method and requirements (phase 2, step 2)
immediate downloadReleased: 2026-04-09
BS EN 16615:2026 Chemical disinfectants and antiseptics. Quantitative test method for the evaluation of bactericidal and yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity on non-porous surfaces with mechanical action employing wipes or mops in the medical area (4- field test). Test method and requirements (phase 2, step 2)

BS EN 16615:2026

Chemical disinfectants and antiseptics. Quantitative test method for the evaluation of bactericidal and yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity on non-porous surfaces with mechanical action employing wipes or mops in the medical area (4- field test). Test method and requirements (phase 2, step 2)

Format
Availability
Price and currency
English Secure PDF
Immediate download
Printable - You are authorized to print 1 copy
431.86 USD
English Hardcopy
In stock
431.86 USD
Standard number:BS EN 16615:2026
Pages:60
Released:2026-04-09
ISBN:978 0 539 23492 3
Status:Standard
DESCRIPTION

BS EN 16615:2026


This standard BS EN 16615:2026 Chemical disinfectants and antiseptics. Quantitative test method for the evaluation of bactericidal and yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity on non-porous surfaces with mechanical action employing wipes or mops in the medical area (4- field test). Test method and requirements (phase 2, step 2) is classified in these ICS categories:
  • 11.080.20 Disinfectants and antiseptics
This document specifies a test method and the minimum requirements for bactericidal and yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity of chemical disinfectant products that form a homogeneous, physically stable preparation when diluted with hard water - or in the case of ready-to-use products - with water. This document is applicable to products that are used in the medical area for disinfecting non-porous surfaces including surfaces of medical devices by wiping or mopping - regardless if they are covered by the Medical Device Regulation [7] or not. Due to the new methods of application of surface disinfectants like pre-impregnated wipes this document was established to cover the different application methods. FprEN 16615 is applicable for four methods of application of products for wiping and/or mopping: a) soaking any non-specified wipe or mop with product; b) spraying the product on any non-specified wipe and / or mop or a specified wipe or mop; c) impregnation of specified wipes or mops by the user with the product according to the manufacturer’s recommendation; d) pre-impregnation of specified wipes or mop by the manufacturer as ready-to-use wipes or mops. In all types of application, the water control is done with the standard wipe (5.3.2.17.1), because it is a process or method control. This document does not apply to products that are sprayed on or flooding surfaces, without wiping in the contact time. In this case, the methods of phase 2/ stage 2 without mechanical action apply. The test-surface (5.3.2.16) was selected as standard surface to cover all non-porous surfaces. This document does not apply to the testing of the influence of different surfaces. This document is applicable to areas and situations where disinfection is medically indicated. Such indications occur in patient care, for example: - in hospitals, in community medical facilities and in dental institutions; - in clinics of schools, of kindergartens and of nursing homes; and can occur in the workplace and in the home. It can also include services such as laundries and kitchens supplying products directly for the patients. NOTE This method corresponds to a phase 2, step 2 test. EN 14885 specifies in detail the relationship of the various tests to one another and to “use recommendations”.
BS EN 16615:2026 - Chemical Disinfectants and Antiseptics

BS EN 16615:2026 - Chemical Disinfectants and Antiseptics

Introducing the BS EN 16615:2026, a comprehensive standard that sets the benchmark for evaluating the efficacy of chemical disinfectants and antiseptics. This standard is crucial for ensuring the highest levels of hygiene and safety in medical environments, where the control of harmful microorganisms is paramount.

Overview

The BS EN 16615:2026 standard provides a quantitative test method for assessing the bactericidal, yeasticidal, fungicidal, tuberculocidal, and mycobactericidal activities of chemical disinfectants and antiseptics. This evaluation is conducted on non-porous surfaces using mechanical action with wipes or mops, specifically tailored for the medical area. The method is known as the 4-field test, which is part of phase 2, step 2 of the testing requirements.

Key Features

  • Standard Number: BS EN 16615:2026
  • Pages: 60
  • Release Date: April 9, 2026
  • ISBN: 978 0 539 23492 3
  • Status: Standard

Why Choose BS EN 16615:2026?

This standard is essential for any organization involved in the production or use of chemical disinfectants and antiseptics within the medical field. It provides a rigorous framework for testing and ensures that products meet the necessary safety and efficacy requirements. By adhering to this standard, manufacturers can guarantee that their products are capable of effectively reducing the presence of harmful microorganisms on surfaces, thereby protecting both healthcare professionals and patients.

Comprehensive Testing Methodology

The BS EN 16615:2026 employs a detailed and structured approach to testing. The 4-field test method is designed to simulate real-world conditions, providing a reliable assessment of a product's performance. This method ensures that the disinfectants and antiseptics are tested under conditions that closely mimic their intended use, offering a high level of confidence in the results.

Wide Range of Microorganisms

This standard covers a broad spectrum of microorganisms, including bacteria, yeasts, fungi, and mycobacteria. It also addresses the specific challenges posed by tuberculosis-causing bacteria, ensuring that products are effective against a wide range of pathogens. This comprehensive coverage makes the BS EN 16615:2026 an invaluable resource for ensuring the safety and hygiene of medical environments.

Applications

The BS EN 16615:2026 is applicable in various settings within the medical field, including:

  • Hospitals and clinics
  • Laboratories
  • Pharmaceutical manufacturing facilities
  • Any environment where the control of microorganisms is critical

Benefits of Compliance

Compliance with the BS EN 16615:2026 standard offers numerous benefits, including:

  • Enhanced Safety: Ensures that disinfectants and antiseptics are effective in reducing harmful microorganisms, thereby enhancing the safety of medical environments.
  • Regulatory Compliance: Helps manufacturers meet regulatory requirements and industry standards, facilitating market access and acceptance.
  • Improved Product Credibility: Products tested and certified according to this standard are recognized for their quality and reliability.
  • Increased Consumer Confidence: Provides assurance to healthcare professionals and patients that the products used are effective and safe.

Conclusion

The BS EN 16615:2026 standard is an essential tool for ensuring the efficacy and safety of chemical disinfectants and antiseptics in the medical field. Its comprehensive testing methodology and wide range of applications make it a critical resource for manufacturers and healthcare providers alike. By adhering to this standard, organizations can ensure that their products meet the highest standards of quality and performance, ultimately contributing to safer and more hygienic medical environments.